News Focus
News Focus
icon url

maverick_1

08/09/15 6:27 AM

#116926 RE: nerby #116159

I'd say you (should really be CTIX holders) need quite a bit more fine tuning.



Believe based on my record, let alone professional experience, and results with many companies that the fine tuning necessary is with the holders of CTIX even before that recent terrible SA hit piece's results(Mako?)

Not surprisingly, found recently a well followed and perceptive seer with similar views and length of experience dated last April:
http://seekingalpha.com/article/3086626-cellceutix-comparing-brilacidin-with-soc-daptomycin